Literature DB >> 4657694

[Some disorders of blood sugar metabolism in newborn infants].

C Y Yeung.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4657694     DOI: 10.1007/bf01564575

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


× No keyword cloud information.
  17 in total

1.  Fructosaemia: an inborn error of fructose metabolism.

Authors:  B LEVIN; V G OBERHOLZER; G J SNODGRASS; L STIMMLER; M J WILMERS
Journal:  Arch Dis Child       Date:  1963-06       Impact factor: 3.791

2.  Hypoglycemia due to pancreatic islet cell adenoma.

Authors:  R FRANCOIS; M PRADON; M SHERRER; A R UGLIENGO
Journal:  J Pediatr       Date:  1962-05       Impact factor: 4.406

3.  The impairment of glucogenesis by gram negative infection.

Authors:  K F LaNoue; A D Mason; J P Daniels
Journal:  Metabolism       Date:  1968-07       Impact factor: 8.694

Review 4.  Central nervous system damage and hypoglycemia.

Authors:  R J Blattner
Journal:  J Pediatr       Date:  1968-06       Impact factor: 4.406

5.  Phenobarbitone prophylaxis for neonatal hyperbilirubinemia.

Authors:  C Y Yeung; L S Tam; A Chan; K H Lee
Journal:  Pediatrics       Date:  1971-09       Impact factor: 7.124

6.  Blood sugar changes in neonatal hyperbilirubinaemia and phenobarbitone therapy.

Authors:  C Y Yeung
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

7.  Phenobarbitone enhancement of bromsulphalein clearance in neonatal hyperbilirubinemia.

Authors:  C Y Yeung; V Y Yu
Journal:  Pediatrics       Date:  1971-10       Impact factor: 7.124

8.  Effect of phenobarbital on hyperbilirubinemia and glucuronide formation in newborns.

Authors:  L Stern; N N Khanna; G Levy; S J Yaffe
Journal:  Am J Dis Child       Date:  1970-07

9.  Hypoglycaemia complicating haemolytic disease of the newborn.

Authors:  H V Price
Journal:  Arch Dis Child       Date:  1969-04       Impact factor: 3.791

10.  Jaundice of the newborn and phenobarbitone.

Authors: 
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.